Although with the advent of high-throughput sequencing and other methods, many genetic changes (such as mutations of gene FLT3, NPM1) which were closely related to the prognosis of CN-AML have been discovered, but the pathogenesis and prognostic markers of CN-AML were not yet fully understood. This evidence concerns the gene NPM1 and acute myeloid leukemia.